Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991991 · ClinicalTrials.gov registry record
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
A clinical trial, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- 5
- Enrollment target
NCT00991991: Clinical Trial study, sponsored by Case Comprehensive Cancer Center.
NCT00991991 is a clinical trial that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00991991 was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients with stage I, stage II, or stage III malignant melanoma.
Interventions
- GENETIC gene expression analysis
- OTHER medical chart review
- GENETIC polymerase chain reaction
- GENETIC polymorphism analysis
- OTHER matrix-assisted laser desorption/ionization time of flight mass spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-07 |
| Est. Completion | 2016-03 |
Why NCT00991991 stopped before completion
NCT00991991 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT00991991 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00991991 about?
NCT00991991 is a clinical study titled "Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma". RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer. PURPOSE: This research study is looking at tumor tissue samples from patients with stage I, stage II, or stage III malignant melanoma.
What is the current status of trial NCT00991991?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2009-07. Estimated completion is 2016-03.
What interventions are being tested in trial NCT00991991?
The interventions under investigation include: gene expression analysis (GENETIC), medical chart review (OTHER), polymerase chain reaction (GENETIC), polymorphism analysis (GENETIC), matrix-assisted laser desorption/ionization time of flight mass spectrometry (OTHER).
Who is sponsoring clinical trial NCT00991991?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia